参考文献/References:
[1] Tziastoudi M,Stefanidis I,Zintzaras E.The genetic map of diabetic nephropathy:Evidence from a systematic review and meta-analysis of genetic association studies[J].Clin Kidney J,2020,13(5):768-781.
[2] 郭进京,居 军,徐向红.载脂蛋白E基因多态性、超敏-C反应蛋白与2型糖尿病合并冠心病的相关性探讨[J].陕西医学杂志,2007,36(12):1613-1616.
[3] 武峻艳,王 杰.从中医证候谈载脂蛋白E与阿尔茨海默病的相关性[J].陕西中医,2019,40(8):1109-1111,1115.
[4] Torres-Valadez R,Ramos-Lopez O,Frías-Delgadillo KJ,et al.Impact of ApoE alleles-by-diet interactions on glycemic and lipid features- a cross-sectional study of a cohort of type 2 diabetes patients from western Mexico:Implications for personalized medicine[J].Pharmgenomics Pers Med,2020,13(11):655-663.
[5] Jing L,Li L,Ren X,et al.Role of sortilin and matrix vesicles in nepsilon-carboxymethyl-lysine-induced diabetic atherosclerotic calcification[J].Diabetes Metab Syndr Obes,2020,13(11):4141-4151.
[6] Gonzalez-Aldaco K,Roman S,Torres-Reyes LA,et al.Association of apolipoprotein e2 allele with insulin resistance and risk of type 2 diabetes mellitus among an admixed population of Mexico[J].Diabetes Metab Syndr Obes,2020,13(10):3527-3534.
[7] Sato N.The emerging role of the apolipoproteins ApoE and ApoJ in the interaction between diabetes and Alzheimer disease[J].J Clin Endocrinol Metab,2020,105(11):570-576.
[8] Alhawari H,Jarrar Y,AlKhatib MA,et al.The association of 3-hydroxy-3-methylglutaryl-CoA reductase,apolipoprotein E,and solute carrier organic anion genetic variants with atorvastatin response among jordanian patients with type 2 diabetes[J].Life,2020,10(10):232-238.
[9] 黄 瑞,张利安.非急性期小动脉闭塞性卒中脑微出血与认知功能相关性及出血危险因素研究[J].陕西医学杂志,2018,47(12):1572-1575.
[10] Lumsden AL,Mulugeta A,Zhou A,et al.Apolipoprotein E(ApoE)genotype-associated disease risks:A phenome-wide,registry-based,case-control study utilising the UK Biobank[J].EBioMedicine,2020,59:102954.
[11] Wu CY,Ouk M,Wong YY,et al.Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease,and the role ApoE carrier status[J].Alzheimers Dement,2020,16(12):1663-1673.
[12] Shi J,Cheng Z,Qiu S,et al.Epsilon2 allele and epsilon2-involved genotypes(epsilon2/epsilon2,epsilon2/epsilon3,and epsilon2/epsilon4)may confer the association of ApoE genetic polymorphism with risks of nephropathy in type 2 diabetes:A meta-analysis[J].Lipids Health Dis,2020,19(1):136-144.
[13] Yassine HN,Anderson A,Brinton R,et al.Do menopausal status and APOE4 genotype alter the long-term effects of intensive lifestyle intervention on cognitive function in women with type 2 diabetes mellitus?[J].Neurobiol Aging,2020,92(8):61-72.
[14] Shinohara M,Tashiro Y,Suzuki K,et al.Interaction between ApoE genotype and diabetes in cognitive decline[J].Alzheimers Dement(Amst),2020,12(1):e12006.
[15] Uddin MS,Kabir MT,Mamun AA,et al.ApoE and Alzheimer's disease:Evidence mounts that targeting APOE4 may combat Alzheimer's pathogenesis[J].Mol Neurobiol,2018,56(4):2450-2465.
[16] Taskinen MR,Björnson E,Kahri J,et al.Effects of evolocumab on the postprandial kinetics of apo(apolipoprotein)B100- and B48-containing lipoproteins in subjects with type 2 diabetes[J].Arterioscler Thromb Vasc Biol,2020,24(12):817-824.
[17] Nelson AJ,Nicholls SJ.Treating dyslipidemia in type 2 diabetes[J].Cardiol Clin,2018,36(2):233-239.
[18] Athyros VG,Doumas M,Imprialos KP,et al.Diabetes and lipid metabolism[J].Hormones(Athens),2018,17(1):61-67.
[19] Luo J,Xu Q,Jiang B,et al.Selectivity,cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor[J].Br J Pharmacol,2018,175(1):140-153.
[20] Hsu H,Hsu P,Cheng MH,et al.Lipoprotein subfractions and glucose homeostasis in prediabetes and diabetes in Taiwan[J].J Atheroscler Thromb,2019,26(10):890-914.
[21] Adam S,Liu Y,Siahmansur T,et al.Bariatric surgery as a model to explore the basis and consequences of the reaven hypothesis:Small,dense low-density lipoprotein and interleukin-6[J].Diab Vasc Dis Res,2019,16(2):144-152.
相似文献/References:
[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]郭向东,马 波△.2型糖尿病患者血清胰岛素水平与骨代谢关联研究*[J].陕西医学杂志,2019,(1):77.
GUO Xiangdong,MA Bo..Association between serum insulin level and bone metabolismin patients with type 2 diabetes mellitus[J].,2019,(6):77.
[3]刘毅龙,陈鹏宇,雷 江,等.SGLT2抑制剂在2型糖尿病合并心血管疾病治疗中的应用研究进展[J].陕西医学杂志,2019,(3):407.
[4]姚爱红.利拉鲁肽治疗2型糖尿病效果及对患者血脂、颈动脉内膜中层厚度的影响[J].陕西医学杂志,2019,(4):518.
YAO Aihong..Effect of liraglutide on type 2 diabetes mellitus in patients with blood lipids and carotid intimamedia thickness[J].,2019,(6):518.
[5]李忆琴,吴礼凤,余晓君,等.中年2型糖尿病患者病程和HbA1c水平与认知功能相关性研究*[J].陕西医学杂志,2019,(6):722.
[6]徐 琳,贾睿博△,宋民喜,等.颗粒蛋白前体与糖尿病肾病关系探讨*[J].陕西医学杂志,2019,(8):1024.
[7]王荣锋,郁 昊,蒋新建.老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J].陕西医学杂志,2019,(8):1032.
WANG Rongfeng,YU Hao,JIANG Xinjian..The relationship between serum 25 hydroxy vitamin D and osteoporosis in elderly diabetic patients[J].,2019,(6):1032.
[8]王 荣,贾爱华,刘新艳 ,等.IGF1及其相关性因素对2型糖尿病并发骨质疏松的影响研究[J].陕西医学杂志,2019,(9):1163.
WANG Rong,JIA Aihua,LIU Xinyan,et al.The effect of IGF1 and its related factors in type 2 diabetes complicated with osteoporosis[J].,2019,(6):1163.
[9]贾睿博,徐 琳△.2型糖尿病患者下肢血管病变相关危险因素调查研究[J].陕西医学杂志,2019,(11):1567.
[10]郭建强,赵俊宏,张分队,等.2型糖尿病视网膜病变患者血清HbA1c、CysC检测及临床意义*[J].陕西医学杂志,2020,49(5):619.
GUO Jianqiang,ZHAO Junhong,ZHANG Fendui,et al.Changes of serum HbA1c and CysC in patients with type 2 diabetic retinopathy and their clinical significance[J].,2020,49(6):619.